ConductScience.org, home

Paper8092339

Naltrexone-induced alterations in human ethanol intoxication.

Swift RM and 4 others. Am J Psychiatry, 1994. Cited by 219 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Naltrexone-induced alterations in human ethanol intoxication. Papers, record 8092339. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8092339

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Naltrexone-induced alterations in human ethanol intoxication.
PubMed
Journal
Am J Psychiatry
PubMed
Year
1994
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
219
iCite
Relative citation ratio, by iCite
9.27
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Swift RMR M
2Whelihan WW
3Kuznetsov OO
4Buongiorno GG
5Hsuing HH

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alcoholic IntoxicationMajor topic
AlcoholismMajor topic
NaltrexoneMajor topic
Administration, Oral
Adult
Affect
Alcohol Drinking
Ambulatory Care
Animals
Cognition
Double-Blind Method
Ethanol
Female
Humans
Male
Middle Aged
Placebos
Psychomotor Performance
Recurrence
Sensation

Source PubMed

Download CSV of topics

Cited by66

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 219 citations.

PMIDTitleJournalYearIn PapersSource
42602047Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing.Front Neurosci2026https://conductscience.org/library/papers/42602047PubMed
36068473Pharmacogenetics of Addiction Therapy.Methods Mol Biol2022https://conductscience.org/library/papers/36068473PubMed
34731268
An inpatient human laboratory study assessing the safety and tolerability, pharmacokinetics, and biobehavioral effect of GET 73 when co-administered with alcohol in individuals with alcohol use disorder.
Psychopharmacology (Berl)2022https://conductscience.org/library/papers/34731268PubMed
33235284Do behavioral pharmacology findings predict clinical trial outcomes? A proof-of-concept in medication development for alcohol use disorder.Neuropsychopharmacology2021https://conductscience.org/library/papers/33235284PubMed
32116535Alcohol Intoxication and Cognition: Implications on Mechanisms and Therapeutic Strategies.Front Neurosci2020https://conductscience.org/library/papers/32116535PubMed
31950152Alcohol Tolerance in Human Laboratory Studies for Development of Medications to treat Alcohol Use Disorder.Alcohol Alcohol2020https://conductscience.org/library/papers/31950152PubMed
31798041Naltrexone and the Treatment of Alcohol Dependence.Alcohol Health Res World1994https://conductscience.org/library/papers/31798041PubMed
31148304Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta-analysis.Addict Biol2019https://conductscience.org/library/papers/31148304PubMed
29438157Effects of Varenicline Alone and in Combination With Low-dose Naltrexone on Alcohol-primed Smoking in Heavy-drinking Tobacco Users: A Preliminary Laboratory Study.J Addict Med2018https://conductscience.org/library/papers/29438157PubMed
29265379Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.Alcohol Clin Exp Res2018https://conductscience.org/library/papers/29265379PubMed
28780411Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.Brain Res Bull2018https://conductscience.org/library/papers/28780411PubMed
28093021Altering ethanol pharmacokinetics to treat alcohol use disorder: Can you teach an old dog new tricks?J Psychopharmacol2017https://conductscience.org/library/papers/28093021PubMed
27411969Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.Addict Biol2017https://conductscience.org/library/papers/27411969PubMed
27266992Experimental psychopathology paradigms for alcohol use disorders: Applications for translational research.Behav Res Ther2016https://conductscience.org/library/papers/27266992PubMed
26772405Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders.Biol Psychiatry2016https://conductscience.org/library/papers/26772405PubMed
26625893Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens.Int J Neuropsychopharmacol2016https://conductscience.org/library/papers/26625893PubMed
26117308A Prospective 5-Year Re-examination of Alcohol Response in Heavy Drinkers Progressing in Alcohol Use Disorder.Biol Psychiatry2016https://conductscience.org/library/papers/26117308PubMed
25833022Effects of idazoxan on alcohol pharmacokinetics and intoxication: a preliminary human laboratory study.Alcohol Clin Exp Res2015https://conductscience.org/library/papers/25833022PubMed
25747925Pharmacotherapy for alcohol use disorder: current and emerging therapies.Harv Rev Psychiatry2015https://conductscience.org/library/papers/25747925PubMed
25664775N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers.Alcohol Clin Exp Res2015https://conductscience.org/library/papers/25664775PubMed

See all 66 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8092339

GET https://conductscience.org/api/papers/v1/8092339/cited_by?page=2